175 related articles for article (PubMed ID: 3331321)
1. Innovative drug delivery systems in cardiovascular medicine: nifedipine-GITS and clonidine-TTS.
Frishman WH; Sherman D; Feinfeld DA
Cardiol Clin; 1987 Nov; 5(4):703-16. PubMed ID: 3331321
[TBL] [Abstract][Full Text] [Related]
2. P&T Committee review of nifedipine GITS: new modality for angina and hypertension.
Weintraub M; Horn J; Krakoff L; Vetrovec G
Hosp Formul; 1990 Mar; 25 Suppl A():10-4. PubMed ID: 10103975
[TBL] [Abstract][Full Text] [Related]
3. Comparative efficacy of two long-acting formulations of nifedipine in the treatment of hypertension. The Switch Study Investigators.
Myers MG; Toal CB
Can J Cardiol; 1995 Nov; 11(10):913-7. PubMed ID: 7489530
[TBL] [Abstract][Full Text] [Related]
4. Monotherapy with nifedipine GITS compared with atenolol in stable angina pectoris. The Working Group on Cardiovascular Research (WCN).
de Vries RJ; Dunselman PH
Br J Clin Pract Suppl; 1997 Apr; 88():6-9. PubMed ID: 9519501
[TBL] [Abstract][Full Text] [Related]
5. Once-daily therapy for angina pectoris with nifedipine gastrointestinal therapeutic system. Dosing and clinical efficacy.
Vetrovec GW
Am J Med; 1989 Jan; 86(1A):28-32. PubMed ID: 2644830
[TBL] [Abstract][Full Text] [Related]
6. Nifedipine gastrointestinal therapeutic system (GITS). A review of its pharmacodynamic and pharmacokinetic properties and therapeutic efficacy in hypertension and angina pectoris.
Brogden RN; McTavish D
Drugs; 1995 Sep; 50(3):495-512. PubMed ID: 8521771
[TBL] [Abstract][Full Text] [Related]
7. [Update in drug delivery system in the field of cardiovascular system].
Satoh Y; Taniguchi K
Nihon Rinsho; 1989 Jun; 47(6):1347-52. PubMed ID: 2504980
[No Abstract] [Full Text] [Related]
8. Nifedipine gastrointestinal therapeutic system in stable angina pectoris. Results of a multicenter open-label crossover comparison with standard nifedipine.
Vetrovec GW; Parker VE; Cole S; Procacci PM; Tabatznik B; Terry R
Am J Med; 1987 Dec; 83(6B):24-9. PubMed ID: 3140660
[TBL] [Abstract][Full Text] [Related]
9. Once daily nifedipine: the formulation dictates the pharmacokinetic characteristics and the therapeutic responses.
Toal CB; Meredith PA; Elliott HL
Int J Clin Pharmacol Ther; 2012 Mar; 50(3):202-17. PubMed ID: 22373833
[TBL] [Abstract][Full Text] [Related]
10. Efficacy and tolerability of extended-release felodipine and extended-release nifedipine in patients with mild-to-moderate essential hypertension.
Fagan TC; Haggert BE; Liss C
Clin Ther; 1994; 16(4):634-46. PubMed ID: 7982251
[TBL] [Abstract][Full Text] [Related]
11. Conversion from sustained-release to immediate-release calcium entry blockers: outcome in patients with mild-to-moderate hypertension.
Hilleman DE; Mohiuddin SM; Lucas BD; Shinn B; Elsasser GN
Clin Ther; 1993; 15(6):1002-10. PubMed ID: 8111798
[TBL] [Abstract][Full Text] [Related]
12. [Acute reduction of blood pressure: comparative study of nifedipine and clonidine].
Dondici Filho J; Gomes JC; de Castro EG; Luz NS; Abzaid A
Arq Bras Cardiol; 1991 Feb; 56(2):127-30. PubMed ID: 1872724
[TBL] [Abstract][Full Text] [Related]
13. Nifedipine gastrointestinal therapeutic system--hypertension management to improve cardiovascular outcomes.
Heagerty AM
Int J Clin Pract; 2005 Sep; 59(9):1112-9. PubMed ID: 16115193
[TBL] [Abstract][Full Text] [Related]
14. Dose- and administration time-dependent effects of nifedipine gits on ambulatory blood pressure in hypertensive subjects.
Hermida RC; Calvo C; Ayala DE; López JE; Rodríguez M; Chayán L; Mojón A; Fontao MJ; Fernández JR
Chronobiol Int; 2007; 24(3):471-93. PubMed ID: 17612946
[TBL] [Abstract][Full Text] [Related]
15. Trough and peak effects of a single daily dose of nifedipine gastrointestinal therapeutic system (GITS) as assessed by ambulatory blood pressure monitoring. Italian Nifedipine GITS Study Group.
Zanchetti A
J Hypertens Suppl; 1994 Jul; 12(5):S23-7. PubMed ID: 7965282
[TBL] [Abstract][Full Text] [Related]
16. The nifedipine gastrointestinal therapeutic system (GITS). Evaluation of pharmaceutical, pharmacokinetic and pharmacological properties.
Grundy JS; Foster RT
Clin Pharmacokinet; 1996 Jan; 30(1):28-51. PubMed ID: 8846626
[TBL] [Abstract][Full Text] [Related]
17. Comparison of sustained-release and standard preparations of clonidine in essential hypertension.
Fyhrquist F
Int J Clin Pharmacol Ther Toxicol; 1983 Dec; 21(12):634-6. PubMed ID: 6365808
[TBL] [Abstract][Full Text] [Related]
18. Comparative effects of felodipine ER, amlodipine and nifedipine GITS on 24 h blood pressure control and trough to peak ratios in mild to moderate ambulatory hypertension: a forced titration study.
Lefebvre J; Poirier L; Archambault F; Jewell D; Reed CV; Lacourcière Y
Can J Cardiol; 1998 May; 14(5):682-8. PubMed ID: 9627524
[TBL] [Abstract][Full Text] [Related]
19. Usefulness of nifedipine for myocardial ischemia and the nifedipine gastrointestinal therapeutic system.
Bittar N
Am J Cardiol; 1989 Sep; 64(11):31F-34F. PubMed ID: 2675587
[TBL] [Abstract][Full Text] [Related]
20. Sustained release nifedipine formulations. An appraisal of their current uses and prospective roles in the treatment of hypertension, ischaemic heart disease and peripheral vascular disorders.
Murdoch D; Brogden RN
Drugs; 1991 May; 41(5):737-79. PubMed ID: 1712708
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
